Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector

Molecular Therapy

Volumn 15, Issue 2, 2007, Pages 393-403

  Hensley, Scott E ^a,b   Cun, Ann S ^b   Giles Davis, Wynetta ^b   Li, Yan ^b   Xiang, Zhiquan ^b   Lasaro, Marcio O ^b   Williams, Bryan R G ^c   Silverman, Robert H ^c   Ertl, Hildegund C J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN G1 ANTIBODY; INTERFERON; INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSPOT ASSAY; HELPER CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; SIGNAL TRANSDUCTION; TRANSGENE; VACCINATION; WILD TYPE;

ADENOVIRIDAE; ANIMALS; BONE MARROW CELLS; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAN TROGLODYTES; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; TH2 CELLS;

ADENOVIRIDAE; CHIMPANZEE ADENOVIRUS; MUS; PAN;

EID: 33846314750     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300024     Document Type: Article

References (46)

1. Tatsis, N and Ertl, HC (2004). Adenoviruses as vaccine vectors. Mol Ther 10: 616-629.
2. Xiang, ZQ, Yang, Y, Wilson, JM and Ertl, HC (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219: 220-227.
3. Xiang, Z, Gao, G, Reyes-Sandoval, A, Cohen, CJ, Li, Y and Bergelson, JM et al. (2002). Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J Virol 76: 2667-2675.
4. Sullivan, NJ, Sanchez, A, Rollin, PE, Yang, ZY and Nabel, GJ (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408: 605-609.
5. Kobinger, GP, Feldmann, H, Zhi, Y, Schumer, G, Gao, G and Feldmann, F et al. (2006). Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346: 394-401.
6. Worgall, S, Krause, A, Rivara, M, Hee, KK, Vintayen, EV and Hackett, NR et al. (2005). Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid. J Clin Invest 115: 1281-1289.
7. Reyes-Sandoval, A, Fitzgerald, JC, Grant, R, Roy, S, Xiang, ZQ and Li, Y et al. (2004). Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J Virol 78: 7392-7399.
8. Seaman, MS, Xu, L, Beaudry, K, Martin, KL, Beddall, MH and Miura, A et al. (2005). Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J Virol 79: 2956-2963.
9. Bruna-Romero, O, Gonzalez-Aseguinolaza, G, Hafalla, JC, Tsuji, M and Nussenzweig, RS (2001). Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci USA 98: 11491-11496.
10. Ophorst, OJ, Radosevic, K, Havenga, MJ, Pau, MG, Holterman, L and Berkhout, B et al. (2006). Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun 74: 313-320.
11. Park, JM, Terabe, M, Sakai, Y, Munasinghe, J, Forni, G, Morris, JC and Berzofsky, JA et al. (2005). Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas. J Immunol 174: 4228-4236.
12. Farina, SF et al. (2001). Replication-defective vector based on a chimpanzee adenovirus. J Virol 75: 11603-11613.
13. Banchereau, J and Steinman, RM (1998). Dendritic cells and the control of immunity. Nature 392: 245-252.
14. Finkelman, FD, Holmes, J, Katona, IM, Urban, IF Jr, Beckmann, MP and Park, LS et al. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8: 303-333.
15. Balazs, M, Martin, F, Zhou, T and Kearney, J (2002). Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
16. Litinskiy, MB, Nardelli, B, Hilbert, DM, He, B, Schaffer, A and Casali, P et al. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3: 822-829.
17. Dubois, B, Massarcier, C, Vanberlvliet, B, Fayette, J, Briere, F and Banchereau, J et al. (1998). Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 161: 2223-2231.
18. Hensley, SE, Giles-Davis, W, McCoy, KC, Weninger, W and Ertl, HC (2005). Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J Immunol 175: 6032-6041.
19. Varnavski, AN, Schlienger, K, Bergelson, JM, Gao, GP and Wilson, JM (2003). Efficient transduction of human monocyte-derived dendritic cells by chimpanzeederived adenoviral vector. Hum Gene Ther 14: 533-544.
20. Huarte, E, Larrea, E, Hernandez-Alcoceba, R, Alfaro, C, Murillo, O and Arina, A et al. (2006). Recombinant Adenoviral Vectors Turn on the Type I Interferon System without Inhibition of Transgene Expression and Viral Replication. Mol Ther 14: 129-138.
21. Le Bon, A, Schiavoni, G, D'Agostino, G, Gresser, I, Belardelli, F and Tough, DF (2001). Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470.
22. Jego, G, Palucka, AK, Blanck, JP, Chalouni, C, Pascual, V and Banchereau, J (2003). Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234.
23. Mosmann, TR and Coffman, RL (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
24. Kapsenberg, ML (2003). Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3: 984-993.
25. Gautier, G, Humbert, M, Deauvieau, F, Scuiller, M, Hiscott, J and Bates, EE et al. (2005). A type I interferon autocrine-paracrine loop is involved in Toll-like receptorinduced interleukin-12p70 secretion by dendritic cells. J Exp Med 201: 1435-1446.
26. Wu, L, Kong, WP and Nabel, GJ (2005). Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens. J Virol 79: 8024-8031.
27. Zelazowski, P, Collins, JT, Dunnick, W and Snapper, CM (1995). Antigen receptor cross-linking differentially regulates germ-line CH ribonucleic acid expression in murine B cells. J Immunol 154: 1223-1231.
28. Silverman, RH (1997). 2-5A dependent RNase L: A regulated endoribonuclease in the interferon system In: GaR D'Alessio JF (ed). Ribonucleases: Structure and Functions. Academic Press: New York, pp 515-551.
29. Meurs, E, Chong, K, Galabru, J, Thomas, NS, Kerr, IM and Williams, BR et al. (1990). Molecular cloning and characterization of the human double-stranded RNAactivated protein kinase induced by interferon. Cell 62: 379-390.
30. Vignaux, F, Gresser, I and Fridman, WH (1980). Effect of virus-induced interferon on the antibody response of suckling and adult mice. Eur J Immunol 10: 767-772.
31. De Maeyer, E and De Maeyer-Guignard, J (1980). Host genotype influences immunomodulation by interferon. Nature 284: 173-175.
32. Le Bon, A, Thompson, C, Karmphuis, E, Durand, V, Rossmann, C and Kalinke, U et al. (2006). Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol 176: 2074-2078.
33. Yang, Y, Jooss, KU, Su, Q, Ertl, HC and Wilson, JM (1996). Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 3: 137-144.
34. Liu, Q and Muruve, DA (2003). Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 10: 935-940.
35. Paul, WE (2003). Fundamental Immunology, Lippincott Williams and Wilkins: Philadelphia, PA.
36. Basner-Tschakarjan, E, Gaffal, E, O'Keeffe, M, Tormo, D, Limmer, A and Wagner, H et al. (2006). Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J Gene Med doi: 10.1002/jgm.964. published online 4 Sept 2006.
37. Qin, L, Ding, Y, Pahud, DR, Chang, E, Imperiale, MJ and Bromberg, JS (1997). Promoter attenuation in gene therapy: Interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 8: 2019-2029.
38. Zhi, Y et al. (2005). Identification of murine CD8T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. Virology 335: 34-45.
39. Muller, U, Steinhoff, U, Reis, LF, Hemmi, S, Pavlovic, J and Zinkernagel, RM et al. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
40. Yang, YL, Reis, LF, Pavlovic, J, Aguzzi, A, Schafer, R and Kumar, A et al. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14: 6095-6106.
41. Zhou, A, Paranjape, J, Brown, TL, Nie, H, Naik, S and Dong, B et al. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylatedependent RNase L. EMBO J 16: 6355-6363.
42. Tatsis, N, Tesema, L, Robinson, ER, Giles-Davis, W, McCoy, K and Gao, GP et al. (2006). Chimpanzee-origin adenovirus vectors as vaccine carriers. Gene Ther 13: 421-429.
43. Lutz, MB, Kukutsch, N, Ogilvie, AL, Rossner, S, Koch, F and Romani, N et al. (1999). An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
44. Asselin-Paturel, C, Boonstra, A, Dalod, M, Durand, I, Yessaad, N and Dezutter-Dambuyant, C et al. (2001). Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2: 1144-1150.
45. Pickles, RJ, McCarty, D, Matsui, H, Hart, PJ, Randell, SH and Boucher, RC (1998). Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 72: 6014-6023.
46. Xiang, ZQ, Knowles, BB, McCarrick, JW and Ertl, HC (1995). Immune effector mechanisms required for protection to rabies virus. Virology 214: 398-404.